Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes -- Ignore unavailable to you. Want to Upgrade?

To: xbrent who wrote (1804)	3/24/1998 10:08:00 AM
From: TokyoMex	Read Replies (3) \| Respond to of 34592

ABMI broke out major , yesterday ,, I think this has a room to go to 1 1/2 - 2 ,, IMHO ABMI -- American Bio-Med is a catheter company which creates silicon based catheters and holds numerous patents now, with more in the patent pipeline. I was told (and it supposedly was not be public knowledge) that they are going to be announcing two contracts in the next week or two for OEMing their materials, and that one of the parties is a very big name in the field. I was also told that they are being considered for a buyout by a big name company, who has wined and dined them. How far these buyout negotiations have gone, I do not know, but they may be a prime candidate for buyout, because of the value of the patents they hold. This stock is still under a dollar, though it popped to .99 today before backing off to .7. Having started the day at .49, that was a fairly good run, I'd say, probably preliminary to a contract announcement. One of our member who is a MD notes... "Currently most MICUs and SICUs (including ours) use polyvinyl chloride catheters for various lines and such. The latest trend is to now try to lower the incidence of line infection with antibiotic-impregnated polyvinyl catheters which cost more than conventional catheters. Silicon-based catheters like those made by ABMI are more expensive but less prone to infection and may compete with the impregnated polyvinyl ones. " This company is not currently profitable and their time line for profitability may be up to a year. On the negative side, they will be announcing a private placement in the future. The exact terms have not been determined but the buyers will be able to buy at 28% below market and will have to hold a long period of time. This will not be a Reg-S deal and I don't know exactly when it will be announced. American Biomed, Inc. (OTC:ABMI) 10077 Grogan's Mill Road The Woodlands, TX 77380 (281) 367-3895 Sector: Healthcare Industry: Medical Equipment & Supplies Complete Financials: SEP 1997 Earnings Announcement: N/A Business Summary BRIEF: ABMI is a development stage company engaged in the development, manufacture and marketing of medical devices. ABMI's primary technology is directed at interventional cardiology, endovascular surgery and minimally invasive surgical devices. For the 9 mos. ended 9/97, net sales fell 14% to $361K. Net loss applic. to Common fell 25% to $1.8M. Results reflect the ineffectiveness of the sales team, offset by productivity improvements and lower borrowings. RATIOS AND STATISTICS AT A GLANCE (As of 03/20/98) Price $ 0.49 EPS (TTM) $ -0.22 52 Week High $ 2.06 P/E Ratio (TTM) NM 52 Week Low $ 0.44 Book Value(MRQ) 0.06 3 Month Avg Daily Vol (Mil) 0.00 Price/Book (MRQ) 8.61 Beta 0.83 Sales Per Share (TTM) $ 0.04 Market Cap (Mil) $ 8.49 Return on Assets (TTM) % -82.40 Shares Outstanding (Mil) 17.33 Return on Equity (TTM) % -416.32 Float (Mil) 14.90 Cash Per Share (MRQ) $ 0.04